STAT+: Tau in the spotlight at Alzheimer’s conference

At the recent Alzheimer’s Association International Conference, scientists zeroed in on tau proteins as a critical factor in the progression of Alzheimer’s disease, highlighting significant strides in crossing the blood-brain barrier to target these proteins more effectively. This focus on tau is pivotal because it may unlock new treatment avenues that directly tackle the underlying causes of Alzheimer’s, rather than just managing symptoms. The implications are huge, as understanding and manipulating tau could lead to breakthroughs in slowing or even halting the disease’s advance. The conference underscored the growing consensus that targeting tau is essential for future Alzheimer’s therapies.